线粒体呼吸链复合体Ⅰ

线粒体呼吸链复合体Ⅰ(简称复合体Ⅰ)是呼吸链电子传递的起始复合体,作为电子传递过程的限速酶,复合体Ⅰ的分子量远大于其余的四个呼吸链复合体。复合体Ⅰ相关的疾病发生除了与40余个复合体Ⅰ组成亚基的突变相关外,还同参与其组装的多个组装因子存在密切联系。该文对复合体I的结构以及参与调控复合体Ⅰ组装的各类组装因子进行了综述,旨在为全面了解复合体Ⅰ相关疾病的发生提供具体参考。     

运动调控线粒体呼吸链超级复合体的研究进展

线粒体呼吸链超级复合体(mitochondrial respiratory chain supercomplex, mitoSC)是线粒体内膜呼吸链上的自由复合体通过其亚基之间的相互作用形成的复合体超级组装,主要为mitoSCⅠ_1+Ⅲ_2+Ⅳ_(1-4)、mitoSCⅠ_1+Ⅲ_2、mitoSCⅢ_2+Ⅳ_(1-2)、高分子量mitoSC (high molecular weight mitoSC, HMW mitoSC)和巨型超级复合体(mitochondrial metacomplex, mitoMC)。mitoSC已被证明具有提高呼吸链电子传递效率、减少活性氧产生的功能。在衰老的不同组织和诸多线粒体相关疾病组织中,mitoSC的种类和含量发生变化。本文通过归纳人类和哺乳动物不同组织中mitoSC的结构和功能,总结衰老、心脏疾病、2型糖尿病、癌症和基因缺陷疾病等条件下mitoSC的变化规律,重点探讨运动对mitoSC的影响及其相关调节机制,为线粒体相关疾病的运动干预提供参考。     

线粒体电子传递系统的组装及其生物学意义

电子传递链亦称呼吸链,由位于线粒体内膜的I、II、III、IV 4种复合物组成,负责电子传递和产生质子梯度。电子主要从复合物I进入电子传递链,经复合物III传递至复合物IV。电子传递系统的组装是一个十分复杂的过程,目前已知主要有约69个结构亚基以及至少16个组装因子参与了人类复合物I、III、IV的组装,这些蛋白质由核基因组与线粒体基因组共同编码。对线粒体电子传递系统的蛋白质组成及其结构已研究得较为清楚,但对它们的组装了解得还比较初步。许多人类线粒体疾病是由于电子传递系统的功能障碍引起的,其中又有许多是由于该系统中一个或多个部件的错误组装引起的。研究这些缺陷不仅能够加深对线粒体疾病发病机理的了解,也有助于揭示线粒体功能的调控机制。将着重对电子传递系统复合物的组装及其与人类疾病关系的研究进展进行综述。     

线粒体呼吸链膜蛋白复合体的结构

线粒体作为真核细胞的重要“能量工厂”,是细胞进行呼吸作用的场所,呼吸作用包括柠檬酸循环和氧化磷酸化两个过程,其中氧化磷酸化过程的电子传递链（又称线粒体呼吸链）位于线粒体内膜上,由四个相对分子质量很大的跨膜蛋白复合体（Ⅰ、Ⅱ、Ⅲ、和Ⅳ）、介于Ⅰ／Ⅱ与Ⅲ之间的泛醌以及介于Ⅲ与Ⅳ之间的细胞色素c共同组成。线粒体呼吸链的功能是进行生物氧化,并与称之为复合物V的ATP合成酶（磷酸化过程）相偶联,共同完成氧化磷酸化过程,并生产能量分子ATP。线粒体呼吸链的结构生物学研究对于彻底了解电子传递和能量转化的机理是至关重要的,本文分别论述线粒体呼吸链复合体Ⅰ、Ⅱ、Ⅲ和Ⅳ的结构,并跟踪线粒体呼吸链超复合体的结构研究进展。     

氧化磷酸化的呼吸链途径模式概论

线粒体内氧化供能过程中的重要代谢物主要有丙酮酸、三羧酸循环中间体、氨基酸分解产物、酮体、脂肪酸β-氧化中间体、甘油代谢物、嘧啶碱基分解产物等。线粒体内重要代谢物脱下的电子对或者H原子可以通过复合体Ⅰ、复合体Ⅱ、或者通过辅酶Q等不同方式进入呼吸链进行电子传递并生成不同数量的ATP。因此,依据代谢物成对电子或H原子进入呼吸链的方式可以划分不同的氧化呼吸链途径模式:NADH氧化呼吸链途径、琥珀酸氧化呼吸链途径,以及FADH2氧化呼吸链途径。     

NDUFS3在肿瘤发生发展中的作用及其机制CSCD

NADH脱氢酶[泛醌]铁硫蛋白3(NADH dehydrogenase [ubiquinone] ferrithionein 3, NDUFS3)是线粒体复合体Ⅰ的核心亚基,直接参与呼吸链的电子传递的过程,在人类各组织器官中的表达水平高低不一。NDUFS3参与肿瘤的发生发展,与细胞活性氧ROS(reactive oxygen species)水平,三磷酸腺苷(adenosinetriphosphate, ATP)生成以及Warburg效应密切相关。本文综述了NDUFS3在肿瘤中的作用及其可能分子机制的研究进展。     

NDUFS3在肿瘤发生发展中的作用及其机制

NADH脱氢酶[泛醌]铁硫蛋白3(NADH dehydrogenase [ubiquinone] ferrithionein 3, NDUFS3)是线粒体复合体Ⅰ的核心亚基,直接参与呼吸链的电子传递的过程,在人类各组织器官中的表达水平高低不一。NDUFS3参与肿瘤的发生发展,与细胞活性氧ROS(reactive oxygen species)水平,三磷酸腺苷(adenosinetriphosphate, ATP)生成以及Warburg效应密切相关。本文综述了NDUFS3在肿瘤中的作用及其可能分子机制的研究进展。     

力竭性运动对大鼠肝脏线粒体氧化磷酸化偶联的影响

本文以ＳＤ大鼠三级递增负荷力竭性跑台运动疲劳模型,分别测定了运动后即刻肝脏线粒体;１．呼吸链复合休Ⅰ＋Ⅲ和Ⅱ＋Ⅲ电子传递与质子泵出比值。２．以苹果糖酸＝谷氨酸和琥珀酸为底物的呼吸控制;态３呼吸速度,态４呼吸速率,呼吸控制率和磷／氧比。结果表明;两种呼吸底物启动的线粒体态４呼吸速率分别升高４６．４６和２３．５４％;呼吸链复合体Ⅰ＋Ⅲ和Ⅱ＋Ⅲ的总Ｈ＾３／２ｅ分别降低１８．６３和１５．８９％。     

呼吸作用电子传递过程中的物质与能量转变

总结了参与呼吸作用电子传递的蛋白复合体结构、呼吸电子传递的过程及该过程中的物质与能量转变,为该部分内容的教学和科普提供参考。     

还原型二(三)磷酸吡啶核苷酸[NAD(P)H]脱氢酶复合体及叶绿体呼吸研究进展

除了经过光系统II和光系统I的非循环电子传递以外,围绕光系统I的循环电子传递对维持高效率的光合作用也是不可缺少的,其中叶绿体还原型二(三)磷酸吡啶核苷酸[NAD(P)H]脱氢酶复合体(NDH复合体)介导的循环电子传递是目前研究的热点。随着质体末端氧化酶(PTOX)的发现,NDH参与的循环电子传递与叶绿体呼吸在补充光合作用所需能量以及抵御光氧化胁迫过程中的作用正日渐引起研究者的重视。文章根据近年的研究进展就叶绿体NDH复合体及其介导的循环电子传递与叶绿体呼吸的生理功能做了综述。     

线粒体呼吸链与活性氧

已知有氧真核生物细胞吸收的氧分子绝大部分都是在线粒体呼吸链末端细胞色素氧化酶上通过四步单电子还原生成水。但同时也有1％-2％的氧可在呼吸链中途接受单电子或双电子被部分还原生成超氧（O2·^-和过氧化氢（H2O2）作为呼吸作用的正常代谢产物。此种来源于线粒体呼吸链的O2·^-和H2O2不但在多种病理的氧化损伤中起关键作用,同样它们也是正常生理条件下对多种细胞过程具有基本调控意义的氧还信号。基于Chance实验室约自20世纪70到90年代的早期研究贡献以及20世纪90年代后其他各实验室的研究新进展,我们聚焦于下述四个相关问题的评述和讨论：（1）由于线粒体内膜面积及其含有的呼吸链复合体酶活力远远高出细胞中所有膜系数量和相关酶活力之总和,因而线粒体呼吸链产生的O2·^-和H2O2构成生物体内最大数量ROS的恒定来源;（2）线粒体呼吸链复合体III的Q循环中Qo位点中半醌自由基（UQH·）已明确是O2·^-的单电子来源;还原细胞色素C-P66^SHC是生成H2O2的双电子供体。虽然复合体I也是产生线粒体基质内O2·^-的主要来源,但由于其确切生成位点尚未明确,在invivo条件下能否产生大量O2·^-也尚有争议;（3）线粒体呼吸链产生O2·^-后的分配和跨膜转移涉及其生理病理作用机制和作用靶点等复杂而重要的问题,直到目前尚未意见一致。“质子和O2·^-循环双回路解偶联模型”整合了目前提出的几种假说的联系点,指出H^＋和O2·^-相互作用生成HO2·及其跨膜很可能是这一复杂问题的中心环节,并与O2·^-对“脂肪酸shuttling model”或O2·^-对“UCPS激活”模型形成了内在的联系;（4）线粒体呼吸形成的△P（△ψ和△pH）能直接控制呼吸链的ROS生成,并以非线性（非欧姆）相关方式通过影响Q循环中的Qo半醌的氧还态和寿命来调节O2·^-生成的急速?     

ACE2及其特殊功能

血管紧张素转换酶2（angiotensin—converting enzyme 2,ACE2）是新发现的与血管紧张素转换酶（ACE）相关的羧肽酶,在肾素-血管紧张素系统（rennin-angiotensin system,RAS）中ACE2可以使AngⅡ转换为Ang1-7,从而产生与血管紧张素Ⅱ相反的效应,同时ACE2还可使Ang I转换为Ang1-9。研究发现：ACE2与高血压、SARS以及肾脏、生殖等系统的疾病有着密切的关系。     

The mechanism of proton translocation in respiratory complex I from molecular dynamics

Abstract

Respiratory complex I, the biggest enzyme of respiratory chain, plays a key role in energy production by the mitochondrial respiratory chain and has been implicated in many human neurodegenerative diseases. Recently, the crystal structure of respiratory complex I is reported. We perform 50?ns molecular dynamics simulations on the membrane domain of respiratory complex I under two hypothetical states (oxidized state and reduced state). We find that the density of water molecules in the trans-membrane domain under reduced state is bigger than that under oxidized state. The connecting elements (helix HL and β-hairpins-helix element) fluctuate stronger under reduced state than that under oxidized state, causing more internal water molecules and facilitating the proton conduction. The conformational changes of helix HL and the crucial charged residue Glu in TM5 play key roles in the mechanism of proton translocation. Our results illustrate the dynamic behavior and the potential mechanism of respiratory complex I, which provides the structural basis for drug design of respiratory complex I.     

Respiratory complex I: mechanistic and structural insights provided by the crystal structure of the hydrophilic domain

Complex I of respiratory chains plays a central role in cellular energy production. Mutations in its subunits lead to many human neurodegenerative diseases. Recently, a first atomic structure of the hydrophilic domain of complex I from Thermus thermophilus was determined. This domain represents a catalytic core of the enzyme. It consists of eight different subunits, contains all the redox centers, and comprises more than half of the entire complex. In this review, novel mechanistic implications of the structure are discussed, and the effects of many known mutations of complex I subunits are interpreted in a structural context.     

Expression of Ndi1p, an alternative NADH:ubiquinone oxidoreductase, increases mitochondrial membrane potential in a C. elegans model of mitochondrial disease

The NADH:ubiquinone oxidoreductase or complex I of the mitochondrial respiratory chain is an intricate enzyme with a vital role in energy metabolism. Mutations affecting complex I can affect at least three processes; they can impair the oxidation of NADH, reduce the enzyme's ability to pump protons for the generation of a mitochondrial membrane potential and increase the production of damaging reactive oxygen species. We have previously developed a nematode model of complex I-associated mitochondrial dysfunction that features hallmark characteristics of mitochondrial disease, such as lactic acidosis and decreased respiration. We have expressed the Saccharomyces cerevisiae NDI1 gene, which encodes a single subunit NADH dehydrogenase, in a strain of Caenorhabditis elegans with an impaired complex I. Expression of Ndi1p produces marked improvements in animal fitness and reproduction, increases respiration rates and restores mitochondrial membrane potential to wild type levels. Ndi1p functionally integrates into the nematode respiratory chain and mitigates the deleterious effects of a complex I deficit. However, we have also shown that Ndi1p cannot substitute for the absence of complex I. Nevertheless, the yeast Ndi1p should be considered as a candidate for gene therapy in human diseases involving complex I.     

Redox-Coupled Protonation of Respiratory Complex I: The Hydrophilic Domain

Respiratory complex I, NADH:ubiquinone oxidoreductase, is a large and complex integral membrane enzyme found in respiring bacteria and mitochondria. It is responsible in part for generating the proton gradient necessary for ATP production. Complex I serves as both a proton pump and an entry point for electrons into the respiratory chain. Although complex I is one of the most important of the respiratory complexes, it is also one of the least understood, with detailed structural information only recently available. In this study, full-finite-difference Poisson-Boltzmann calculations of the protonation state of respiratory complex I in various redox states are presented. Since complex I couples the oxidation and reduction of the NADH/ubiquinone redox couple to proton translocation, the interaction of the protonation and redox states of the enzyme are of the utmost significance. Various aspects of complex I function are presented, including the redox-Bohr effect, intercofactor interactions, and the effects of both the protein dielectric and inclusion of the membrane.     

Expression of Ndi1p, an alternative NADH:ubiquinone oxidoreductase, increases mitochondrial membrane potential in a C. elegans model of mitochondrial disease

The NADH:ubiquinone oxidoreductase or complex I of the mitochondrial respiratory chain is an intricate enzyme with a vital role in energy metabolism. Mutations affecting complex I can affect at least three processes; they can impair the oxidation of NADH, reduce the enzyme's ability to pump protons for the generation of a mitochondrial membrane potential and increase the production of damaging reactive oxygen species. We have previously developed a nematode model of complex I-associated mitochondrial dysfunction that features hallmark characteristics of mitochondrial disease, such as lactic acidosis and decreased respiration. We have expressed the Saccharomyces cerevisiae NDI1 gene, which encodes a single subunit NADH dehydrogenase, in a strain of Caenorhabditis elegans with an impaired complex I. Expression of Ndi1p produces marked improvements in animal fitness and reproduction, increases respiration rates and restores mitochondrial membrane potential to wild type levels. Ndi1p functionally integrates into the nematode respiratory chain and mitigates the deleterious effects of a complex I deficit. However, we have also shown that Ndi1p cannot substitute for the absence of complex I. Nevertheless, the yeast Ndi1p should be considered as a candidate for gene therapy in human diseases involving complex I.     

NADH Dehydrogenases: From Basic Science to Biomedicine

This review article is concerned with two on-going research projects in our laboratory, both of which are related to the study of the NADH dehydrogenase enzyme complexes in the respiratory chain. The goal of the first project is to decipher the structure and mechanism of action of the proton-translocating NADH-quinone oxidoreductase (NDH-1) from two bacteria, Paracoccus denitrificans and Thermus thermophilus HB-8. These microorganisms are of particular interest because of the close resemblance of the former (P. denitrificans) to a mammalian mitochondria, and because of the thermostability of the enzymes of the latter (T. thermophilus). The NDH-1 enzyme complex of these and other bacteria is composed of 13 to 14 unlike subunits and has a relatively simple structure relative to the mitochondrial proton-translocating NADH-quinone oxidoreductase (complex I), which is composed of at least 42 different subunits. Therefore, the bacterial NDH-1 is believed to be a useful model for studying the mitochondrial complex I, which is understood to have the most intricate structure of all the membrane-associated enzyme complexes. Recently, the study of the NADH dehydrogenase complex has taken on new urgency as a result of reports that complex I defects are involved in many human mitochondrial diseases. Thus the goal of the second project is to develop possible gene therapies for mitochondrial diseases caused by complex I defects. This project involves attempting to repair complex I defects in the mammalian system using Saccharomyces cerevisiae NDI1 genes, which code for the internal, rotenone-insensitive NADH–quinone oxidoreductase. In this review, we will discuss our progress and the data generated by these two projects to date. In addition, background information and the significance of various approaches employed to pursue these research objectives will be described.